|
|
Optimizing Early Phase Oncology Studies to Accelerate Proof of Concept 2010 is a two day conference that will highlight ethical, academic, essential industry, scientific, regulatory analysis of the latest and most critical issues related to oncology drug development. Participants will understand the procedure followed by experts in pre-clinical and clinical development. This will help them to create a program that satisfies all stakeholders. Further, attendees will learn how to use existing resources to competently run early phase clinical trials for innovative oncology. Participants will be greatly benefit from this event as they will learn the most efficient methods of creating a solid pre-clinical program. They will also be educated about the procedures and formalities required to satisfy governing bodies. The event will provide the members an opportunity to meet with experts who are directly associated with anti-cancer agent trial design and execution.
Visitor Profile
The visitors at Optimizing Early Phase Oncology Studies to Accelerate Proof of Concept 2010 would include VPs, Professors, Senior Directors, Managers and executives associated with:
- Biologics
- Pharmacy
- Biotech
- Small molecules
- Discovery
- Pre-clinical development
- Exploratory development
- Early phase clinical development
- Clinical operations
- Clinical science
- Clinical pharmacology
- Biomarkers
- Licensing
- Translational medicine
- Regulatory affairs
- Therapy
- R&D
Organizer
NextLevel Pharma
